The Influence of Myocardial Revascularization on the Condition of the Distal Part of Coronary Arteries in Patients with Type 2 Diabetes Mellitus

Keywords: coronary artery disease, coronary angiography, atherosclerosis of coronary arteries, coronary artery bypass surgery, percutaneous coronary intervention


The aim. To study the dynamics of the internal lumen of the distal part of coronary arteries after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with type 2 diabetes mellitus

Materials and methods. This retrospective study included 121 patients with coronary artery disease and type 2 diabetes mellitus after revascularization of coronary arteries through PCI or CABG. In order to evaluate the changes in the condition of the distal sections of the coronary arteries after stenting and CABG, we included patients with type 2 diabetes mellitus in whom repeated coronary angiography was performed 12-60 months after PCI or CABG. The quantitative method (quantitative coronary angiography) and semi-quantitative assessment scales were used to assess the dynamics of the distal part of the coronary arteries.

Results. The mean age of the patients was 56.2 ± 0.4 years for patients who underwent CABG and 54.3 ± 0.4 years for patients who underwent PCI. There were 64.7% men in the CABG group and 54.0% in the PCI group. The use of drug-eluting stents didn’t affect the internal lumen of the distal part of the arteries. After implantation of bare metal stents, progression of diffuse atherosclerotic lesions was detected. The use of arterial grafts during CABG improved the condition of the inner lumen of the bypassed vessel. However, after venous grafts placement, the patency of the distal coronary arteries may deteriorate in the future.

Conclusions. In people with type 2 diabetes mellitus and coronary artery disease, after cardiac surgery, the smaller branches of the blood vessels can become narrower over the next 1-5 years if a stent without medication or a vein graft is used. However, when a drug-eluting stent or an artery graft is used, the smaller vessel branches stay about the same or even improve over time.


  1. Aronson D, Edelman ER. Coronary Artery Disease and Diabetes Mellitus. Cardiol Clin. 2014;32(3):439-455.
  2. Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018;391(10124):939-948.
  3. Zhao X, Xu L, Jiang L, Tian J, Zhang Y, Wang D, et al. Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China. Cardiovasc Diabetol. 2021 Jan 11;20(1):16.
  4. Ertan C, Ozeke O, Gul M, Aras D, Topaloglu S, Kisacik HL, et al. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J Cardiol. 2014;63(1):29-34.
  5. Carmona-Segovia ADM, Doncel-Abad MV, Becerra-Muñoz VM, Rodríguez-Capitán J, Sabatel-Pérez F, Flores-López M, et al. Prognostic stratification of older patients with multivessel coronary artery disease treated with percutaneous transluminal coronary angioplasty based on clinical and biochemical measures: protocol for a prospective cohort study. BMJ Open. 2022 Feb 28;12(2):e058042.
  6. Godoy LC, Rao V, Farkouh ME. Diabetes and multivessel disease: coronary artery bypass grafting remains king. Curr Opin Cardiol. 2018;33(5):551-557.
  7. Calé R, Teles RC, Almeida M, Rosário Id, Sousa PJ, Brito J, et al. Percutaneous Coronary Intervention using a Full Metal Jacket with Drug-eluting Stents: Major Adverse Cardiac Events at One Year. Arq Bras Cardiol. 2013;101(2):117-126.
  8. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.
  9. Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, Tranbaugh RF. Arterial Grafts Protect the Native Coronary Vessels From Atherosclerotic Disease Progression. Ann Thorac Surg. 2012;94(2):475-481.
  10. Wakabayashi K, Mintz GS, Weissman NJ, Stone GW, Ellis SG, Grube E, et al. Impact of Drug-Eluting Stents on Distal Vessels. Circ Cardiovasc Interv. 2012;5(2):211-219.
How to Cite
Mankovsky, G. B., & Dzhun, Y. Y. (2024). The Influence of Myocardial Revascularization on the Condition of the Distal Part of Coronary Arteries in Patients with Type 2 Diabetes Mellitus. Ukrainian Journal of Cardiovascular Surgery, 32(1), 20-25.